Open access results lead to advances in acute lymphoblastic leukemia
The BCLQ collects samples coming from many types of cancers, including acute lymphoblastic leukemia (ALL). Select ALL samples were analyzed via RNA sequencing by the Leucegene group who went on to published their findings and ensured that their data was accessible to all researchers. Groups could then access samples that had been fully analyzed and sequenced, which lead to multiple publications and discoveries in the field, including a potential new therapy for ALL. Some of these researchers went on to use open access data in order to obtain grants to support their ongoing projects.